| 1 | 92572 | Preparation of syngeneic tumor regressor serum reactive with the unique determinants of the Abelson murine leukemia virus-encoded P120 protein at the cell surface. | J Virol | 1979 Sep |
3 |
| 2 | 2190605 | Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. | AIDS | 1990 Apr |
1 |
| 3 | 6159451 | Superiority of ABTS over Trinder reagent as chromogen in highly sensitive peroxidase assays for enzyme linked immunoadsorbent assay. | J Clin Chem Clin Biochem | 1980 Jun |
2 |
| 4 | 6159484 | Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50. | J Virol | 1980 Nov |
1 |
| 5 | 7480004 | Cholinergic channel activators: novel opportunities for the treatment of CNS disorders. | Proc West Pharmacol Soc | 1995 |
1 |
| 6 | 7518514 | (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. | J Pharmacol Exp Ther | 1994 Jul |
3 |
| 7 | 7791118 | Characterization of [3H]ABT-418: a novel cholinergic channel ligand. | J Pharmacol Exp Ther | 1995 Jun |
2 |
| 8 | 7913497 | (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. | J Pharmacol Exp Ther | 1994 Jul |
2 |
| 9 | 8558425 | ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease. | J Pharmacol Exp Ther | 1996 Jan |
1 |
| 10 | 8654206 | Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193. | Drug Metab Dispos | 1995 Oct |
3 |
| 11 | 8667228 | Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonist. | J Pharmacol Exp Ther | 1996 Jun |
2 |
| 12 | 8849692 | Artificial peroxidase-like hemoproteins based on antibodies constructed from a specifically designed ortho-carboxy substituted tetraarylporphyrin hapten and exhibiting a high affinity for iron-porphyrins. | FEBS Lett | 1996 Oct 14 |
2 |
| 13 | 8987816 | Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. | J Neurosci | 1996 Dec 15 |
1 |
| 14 | 9151941 | Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist. | Eur J Pharmacol | 1997 Apr 23 |
3 |
| 15 | 9266276 | Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist. | Inflamm Res | 1997 Jul |
2 |
| 16 | 9300870 | Development of a sensitive method for quantitation of ABT-089 in plasma using fluorescence labeling with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole. | J Chromatogr B Biomed Sci Appl | 1997 Aug 1 |
1 |
| 17 | 9336329 | ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties. | J Pharmacol Exp Ther | 1997 Oct |
3 |
| 18 | 9435164 | The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis. | J Pharmacol Exp Ther | 1998 Jan |
2 |
| 19 | 9580626 | ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. | J Pharmacol Exp Ther | 1998 May |
1 |
| 20 | 9580627 | ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization. | J Pharmacol Exp Ther | 1998 May |
2 |
| 21 | 9651224 | Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons. | J Neurosci | 1998 Jul 15 |
1 |
| 22 | 9696850 | In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor. | J Virol | 1998 Sep |
2 |
| 23 | 9763401 | Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor. | Drug Metab Dispos | 1998 Oct |
4 |
| 24 | 9884314 | In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification. | Drug Metab Dispos | 1999 Jan |
2 |
| 25 | 10099073 | Lack of cytochrome P450 1A2 interaction effect of ABT-761 on the pharmacokinetics of theophylline. | Am J Ther | 1998 Sep |
1 |
| 26 | 10421617 | Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. | Drug Metab Dispos | 1999 Aug |
2 |
| 27 | 10479299 | Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ET(B) antagonists containing a diphenylmethylamine acetamide side chain. | J Med Chem | 1999 Sep 9 |
1 |
| 28 | 10704009 | Determination of ABT-089 in human plasma by high performance liquid chromatography using in situ precolumn derivatization with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole. | J Pharm Biomed Anal | 1999 Jun |
1 |
| 29 | 10716232 | The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions. | Neuroreport | 1999 Dec 16 |
5 |
| 30 | 10799477 | Bicarbonate enhances the hydroxylation, nitration, and peroxidation reactions catalyzed by copper, zinc superoxide dismutase. Intermediacy of carbonate anion radical. | J Biol Chem | 2000 May 12 |
1 |
| 31 | 10836715 | Evidence for vasoconstriction mediated by the endothelin-B receptor in domestic swine. | J Cardiovasc Pharmacol | 2000 Jun |
1 |
| 32 | 10906163 | Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans. | J Am Soc Nephrol | 2000 Aug |
4 |
| 33 | 10920058 | Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure. | Circulation | 2000 Aug 1 |
1 |
| 34 | 11049852 | Endothelin and ET(A) receptors in long-term arterial pressure homeostasis in conscious nonhuman primates. | Am J Physiol Regul Integr Comp Physiol | 2000 Nov |
1 |
| 35 | 11073661 | Synthesis of the C-13 side chain precursors of the 9-dihydrotaxane analogue ABT-271. | Org Lett | 2000 Nov 16 |
3 |
| 36 | 11078333 | 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects. | J Cardiovasc Pharmacol | 2000 Nov |
9 |
| 37 | 11078402 | Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level. | J Cardiovasc Pharmacol | 2000 Nov |
1 |
| 38 | 11082453 | ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. | J Pharmacol Exp Ther | 2000 Dec |
1 |
| 39 | 11160616 | Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1. | J Pharmacol Exp Ther | 2001 Feb |
1 |
| 40 | 11334846 | Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy. | Eur J Pharmacol | 2001 Apr 13 |
1 |
| 41 | 11348114 | An efficient synthesis of the taxane-derived anticancer agent ABT-271. | J Org Chem | 2001 May 18 |
1 |
| 42 | 11362207 | ABT-538 increases CD4 counts. | Posit Aware | 1995 Jan-Feb |
1 |
| 43 | 11404288 | Role of ET(A) receptors in experimental ANG II-induced hypertension in rats. | Am J Physiol Regul Integr Comp Physiol | 2001 Jul |
2 |
| 44 | 11426700 | Purification of lactoperoxidase from bovine milk and investigation of the kinetic properties. | Prep Biochem Biotechnol | 2001 May |
1 |
| 45 | 11429654 | Role of endothelin ET(A) receptor antagonism in the post-transplant renal response to angiotensin II in the rat. | Exp Physiol | 2001 May |
1 |
| 46 | 11485318 | Changing the substrate specificity of cytochrome c peroxidase using directed evolution. | Biochem Biophys Res Commun | 2001 Aug 10 |
4 |
| 47 | 11566971 | Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. | J Antimicrob Chemother | 2001 Sep |
1 |
| 48 | 11600044 | Tannin-protein complexes as radical scavengers and radical sinks. | J Agric Food Chem | 2001 Oct |
1 |
| 49 | 11754593 | Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors. | J Med Chem | 2002 Jan 3 |
3 |
| 50 | 11882629 | Function and regulation of endothelin-1 and its receptors in salt sensitive hypertension induced by sensory nerve degeneration. | Hypertension | 2002 Feb |
1 |